|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net earnings | |||||
| Depreciation and amortization | |||||
| Loss on disposal of operations | |||||
| Gains attributable to mortgage servicing rights | |||||
| Gains attributable to the fair value of mortgage premiums and origination fees | |||||
| Deferred tax | |||||
| Equity earnings from non-consolidated investments | |||||
| Stock option expense (note 20) | |||||
| Amortization of advisor loans | |||||
| Contingent consideration (note 7) | |||||
| Other | |||||
| Increase in accounts receivable, prepaid expenses and other assets | |||||
| Increase in accounts payable, accrued expenses and other liabilities | |||||
| Increase (decrease) in accrued compensation | |||||
| Contingent acquisition consideration paid | |||||
| Proceeds received on sale of mortgage loans | |||||
| Principal funded on originated mortgage loans | |||||
| Increase (decrease) in mortgage warehouse credit facilities | |||||
| Sales to (purchases from) AR Facility, net (note 15) | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Acquisitions of businesses, net of cash acquired (note 4) | |||||
| Purchases of fixed assets | |||||
| Advisor loans issued | |||||
| Purchases of warehouse fund assets | |||||
| Proceeds from disposal of warehouse fund assets | |||||
| Equity co-investment contributions (note 16) | |||||
| Collections of AR facility deferred purchase price (note 15) | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Increase in long-term debt | |||||
| Repayment of long-term debt | |||||
| Issuance of subordinate voting shares (note 18) | |||||
| Purchases of non-controlling interests' subsidiary shares, net | |||||
| Sale of non-controlling interests' subsidiary shares | |||||
| Contingent acquisition consideration paid | |||||
| Proceeds received on exercise of stock options | |||||
| Dividends paid to common shareholders | |||||
| Distributions paid to non-controlling interests | |||||
| Repurchases of Subordinate Voting Shares | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...